Product Details
1/UN
$ *.**
In Stock1/EA
$ *.**
In StockEA/EA
$ *.**
In StockAdditional Information
| Product Name | Inflectra 100Mg 20Ml Vl Ea |
| Application | Tumor Necrosis Factor (TNF) Blocker |
| Generic Drug Name | Infliximab-dyyb |
| Mechanism of Action | Binds to TNF-alpha, preventing its interaction with TNF receptors, thereby reducing inflammation |
| Strength | 100 mg |
| Type | Intravenous |
| Volume | 20 mL |
| Adverse Reactions | Infusion-related reactions, infections, hepatotoxicity, malignancies, hypersensitivity reactions |
| Precautions | Screen for TB before initiation; monitor liver function and blood counts regularly |
| Pregnancy Category | Category B – Use only if benefits outweigh risks |
| Monitoring | Liver function tests, complete blood count, signs of infections, and hypersensitivity reactions |
| Container Type | Single-Dose Vial |
| Storage Requirements | Requires Refrigeration (2°C to 8°C / 36°F to 46°F) |
| Indications | Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Psoriatic Arthritis, Plaque Psoriasis |
Description
INFLECTRA® (infliximab-dyyb) is a tumor necrosis factor (TNF) inhibitor used for the treatment of autoimmune diseases. It is a chimeric monoclonal antibody designed to reduce inflammation by targeting TNF-alpha, a cytokine involved in immune responses. INFLECTRA is indicated for conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Serious adverse effects may occur, including an increased risk of infections such as tuberculosis, opportunistic infections, and sepsis. Hypersensitivity reactions, infusion-related reactions, and hepatotoxicity have been reported. Long-term use may increase the risk of malignancies, including lymphoma.
INFLECTRA is contraindicated in patients with severe infections, heart failure, or hypersensitivity to infliximab. Caution is advised in individuals with a history of chronic or recurrent infections, demyelinating disorders, or liver dysfunction. Live vaccines should be avoided during treatment.
Frequently Asked Questions (FAQs)
The cost of INFLECTRA 100MG 20ML VL EA is $$0.00
INFLECTRA 100MG 20ML VL EA is manufactured by Pfizer.
You can purchase INFLECTRA 100MG 20ML VL EA on our website at https://cobalt.pipelinemedical.com/product/detail/inflectra-100mg-20ml-vl-ea-659469